Campus to Host Jan. 17 Tribute to Martin Luther King, Jr.
Campus will host a tribute to Martin Luther King, Jr., at noon, Wednesday, Jan. 17, in the Great Hall, Tangeman University Center.
The event is sponsored by the African American Cultural & Resource Center and is titled Remnants of the Dream: Deferred, Devalued, Yet Deliverable.
The program consists of:
- 11:30 a.m.: Doors open
- 11:45 a.m.-12:05 p.m.: Ngoma and the Black Arts Collaborative
- Noon: Opening presentation: LeLAnd Brown, Carver Ealy and P. Eric Watford
- Opening Remarks: Ms. Kuamka and Mr. Mr. Kuamka 2018
- Official University Welcome: President Neville Pinto
- Additional welcome: Vice President for Student Affairs Debra Merchant
- Official Student Welcomes: Student Government Association, Presidents, United Black Student Association
- Universal Prayer: Leslie Keener, Catholic Campus Minister, University of Cincinnati,St. Monica-St. George Parish Newman Center
- Statement of Deliverables: Eric Abercrumbie, Executive Director, Student Affairs Special Initiatives & Community Relations
- Introduction of Speaker: Habari Gani Ambassador
- Musical selection: AACRC Choir
- Keynote Address: Rev. Damon Lynch, Pastor, New Prospect Baptist Church
- Special Presentation: Mr. & Miss Kuamka
- Closing Remarks: P. Eric Watford, MLK Chair
- "The Charge:"Carver Ealy
See more events celebrating and promoting equity, inclusion and engagement.
Related Stories
2026 Cincinnati Business Courier's '40 Under 40' includes nine UC alumni
August 3, 2026
Nine remarkable University of Cincinnati alumni have been named by the Cincinnati Business Courier to its annual “40 Under 40” Class for 2026.
As Crosley Tower comes down, UC looks to STEM
July 30, 2026
With demolition of Crosley Tower more than halfway complete, the University of Cincinnati is preparing a, 200,000-square-foot STEM Academic Facility on its Uptown campus, transforming the north side of campus with new classrooms and labs.
UC launches trial to reduce radiation for HPV-positive throat cancer
July 30, 2026
UC radiation oncologist Sara Medek is leading a phase II clinical trial testing whether patients with HPV-positive throat cancer can safely receive lower radiation doses to reduce side effects.